The US released a new vaccine against monkeypox called Jynneos due to the late emergence of the virus worldwide in non-epidemic countries, the new regulation was announced on Tuesday.

Jennifer McQuiston, deputy director of the Division of High Consequence Pathogens and Pathology at the CDC’s Emerging and Zoonotic Infectious Diseases Center said: “I can report that there has been a request for release of the Jynneos vaccine from the National Stockpile for some of the high-risk contacts of some of the early patients, so that is actively happening right now.”

In 2019, the vaccine was approved for the first time by the CDC for only high-risk cases before it was re-used for protecting a larger scale of residents.McQuiston added: “Right now, we have over 1,000 doses of that available,” continuing: “We expect that level to ramp up very quickly in the coming weeks as the company provides more doses to us.”

In the same context, the authorities approved another smallpox vaccine named ACAM2000, and it could be used against the monkeypox as well, in addition, the US has more than 100 million doses available from the vaccine.

“ACAM2000 is an older-generation smallpox vaccine that has some potential significant side effects with it,” the official explained. “So, a decision to use that widely would have to have some serious discussion behind it.”The federal health officials consider using some recommended vaccines for people who are in close contact with the current active monkeypox cases to CNN.

Tags: Monkeypox US vaccine